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Abstract 
 
The gram positive spore former constitutes a group of widely distributed infectious 
microorganism which has posed serious threat to public health. This group comprises the 
Bacillus, Clostridium, Staphylococcus and Streptococcus species. The authors reviewed 
the current trends involved in the mode of action in causing disease of man and animals. 
In this study, key gaps knowledge in identification, diagnosis, pathology, epidemiology, 
treatment, prevention and control were brought to the fore, with aim of providing 
knowledge in dealing with quick diagnosis, cure/ prevention of diseases caused by these 
groups of microorganisms. Some of the medically important diseases discussed include: 
anthrax, botulism and tetanus. These diseases have caused serious strain on the budgets 
of most nations in providing prompt diagnosis, treatment and control of such diseases for 
their citizenry.  
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Introduction 
 
Gram positive bacteria have two major groups when phylogenetically classified. They are 
the low G+C and high G+C gram positive bacteria. The low G+C includes the clostridia, the 
bacilli and lactobacilli, mycoplasmas. The clostridia and lactobacilli are endospore formers, 
occurring as cocci and rods. However, this possession of endospores consequently does not 
mean close relatedness. Among the gram positive group, the uniqueness of their different 
peptidoglycan is frequently used for easy identification of the different groups. Aside from 
the peptidoglycan layer, the gram-positive bacteria have polysaccharides and teichoic acids 
present in their structures. The peptidoglycans which are sometimes also called murein are 
heteropolymers of glycan strands, which are cross-linked through short peptides. The murein 
consists of chains of alternating residues of N-acetylglucosamine and N-acetyl muramic acid. 
The muramic acid is a unique substance associated with bacterial cell walls. These chains are 
cross-linked by short polypeptide chains consisting of both L- and D-aminoacids. However, 
among the gram-negative bacteria, the peptidoglycan is simple in structure and comparatively 
uniform throughout most genera.  
Most gram positive bacteria are harmless free living saprophytes, whereas in some 
species are major human pathogens. For the basis of this contribution, we would like to 
discuss some of the groups with high level of medical importance, where we would be 
highlighting on their morphology, pathology, diagnosis and treatments. These groups include 
the Bacilli and Clostridium species. 
Bacilli: Among the gram positive spore forming bacilli are the Bacillus and Clostridium 
species. This gram positive spore formers could almost be found in every environment, due to 
the ability to form spores that can thrive in the environment for many years. Bacillus species 
are aerobes while clostridia are anaerobes. Several species of this group cause medically 
important disease in humans. Notable is anthrax disease caused by the Bacillus anthracis. 
Anthrax affects predominantly animals and occasionally humans. The bacterium is a major 
agent of bioterrorism and biological warfare. Bacillus cereus causes food poisoning and 
occasionally eye or other localized infections. Clostridium species cause several important 
toxin –mediated diseases e.g. Clostridium tetani causes tetanus, Clostridium botulinum causes 
botulism, Clostridium perfringes causes gas gangrene and Clostridium difficle causes pseudo 
membranous’’ colitis. 
 
 
The Bacillus Species 
 
This genus is aerobic, occurring as rods in chains. Most of the members of this genus are 
saprophytic organisms and they are prevalent in soil, water and air. Examples include 
Bacillus cereus and Bacillus subtilis. Some are insect pathogens and can grow in foods, 
producing enterotoxin or emetic toxin that causes food poisoning.  It may occasionally 
produce disease in immunocompromised humans (e.g. meningitis, endocarditis, conjunctivitis 
or acute gastroenteritis). B. anthracis, which causes anthrax, is the principal pathogen of the 
genus and a zoonotic disease. 
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Bacillus Anthracis 
 
Morphology and Identification 
The typical cells of Bacillus anthracis, measures between 1 x 3-4 µm, with rectangular 
ends arranged in long chains. The spores are located in the center, oval in shape and refractile. 
Colonies of B. anthracis are round and have a cut glass appearance in transmitted light. 
Typical colonies have a wavy margin and small projections. The organism is a gram positive 
and survives between 12-45
o
C. Hemolysis is uncommon with B. anthracis but common with 
saprophytic bacilli. The saprophytic bacilli utilize simple sources of nitrogen and carbon for 
energy and growth. The spores are resistant to environmental changes and can withstand dry 
heat at 140
o
C for 1-3hrs but can be destroyed when autoclaved at right temperature and 
pressure. To certain chemical disinfectants, they can be resistant to it for moderate periods 
and persist for years when found in dry earth. Animal products contaminated with anthrax 
spores (e.g. hides, bristles, hair, wool, bone) can be sterilized only by autoclaving. 
 
Pathogenesis 
Anthrax is primarily a disease of herbivores –goats, sheep, cattle and horses. Other 
animals (e.g. rats) are relatively resistant to the infection. Human becomes infected 
incidentally by contact with infected animals and their products. In animals, the portal of 
entry is the mouth and the gastrointestinal tract. Spores from contaminated soil may find easy 
access when ingested with spiny or irritating vegetation. In humans, the infection is by the 
entry/ inoculation of spores through injured skin (cutaneous anthrax forming lesions known 
as malignant pustule) or rarely the mucous membranes (gastrointestinal anthrax) or by 
inhalation of spores into the lung (inhalation anthrax- called the wool-sorters disease). This 
condition could be very fatal due to consequent inflammation, septicemia and hemorrhage. At 
the site of entry, the spores germinate in the tissue into vegetative organisms resulting in 
formation of a gelatinous edema and congestion. Bacillus anthracis spreads via lymphatics to 
the blood stream, and they multiply freely in the blood and tissues /organs such as lung 
shortly before and after the animal’s death. Anthrax toxin is made up of three proteins Lethal 
Factor (LF), Edema Factor (EF), Protective Antigen (PA). 
 
Mode of Action of the Toxin in Cells 
The Protective Antigen (PA) binds to specific cells receptors and following proteolytic 
activation, a membrane channel is formed that mediates entry of Edema Factor (EF) and 
Lethal Factor (LF) into the cell. The binding between the lethal factor (LF) and the protective 
antigen (PA) form a lethal toxin. This toxin is the major virulence factor which causes death 
in infected animals. When injected into laboratory animals, the lethal toxin can quickly kill 
the animals.  In inhalation anthrax, when the spores from the dust on wool, hair or hides are 
inhaled; it is phagocytosed in the lungs and transported by the lymphatic drainage to the 
mediastinal lymph nodes, where germination occurs followed by toxin production and the 
development of hemorrhagic mediastinitis and sepsis, which are usually rapidly fatal. 
 
Pathology 
In susceptible animals such as mammals, Bacillus anthracis proliferate at the site of 
entry. The capsules remain intact, and the organisms are surrounded by a large amount of 
proteinaceous fluid containing few leukocytes from which they rapidly disseminate and reach 
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blood stream. In the resistant animals, the Bacillus anthracis proliferate for few hours by 
which time a massive accumulation of leukocytes is formed and the capsule gradually 
disintegrates and disappears. In humans, approximately 95% of cases are cutaneous anthrax 
and 5% are inhalation .Gastrointestinal anthrax is very rare. It has been reported from Africa, 
Asia and USA following occasions where people have eaten meat from infected animals. 
Cutaneous anthrax generally occurs on exposed surfaces of the arms or hands, face and neck. 
A puritic papule develops between 1-7 days after entry of the organisms or spores through a 
scratch. Initially it resembles an insect bite, which progresses to papule rapidly changing into 
a vesicle or small ring of vesicles that coalesce and necrotic ulcer develops. The lesions 
typically are 1-3 cm in diameter and have a characteristic central black eschar. Systemic signs 
and symptoms of fever, malaise, and headache may occur. After 7-10 days the eschar is fully 
developed. Eventually it dries, loosens and separates. Healing is by granulation and leaves a 
scar. It may take many weeks for the lesion to heal and the edema to subside. Antibiotic 
therapy does not appear to change the natural progression of the disease. In patients, 
cutaneous anthrax can lead to sepsis, which could lead to systemic infection –including 
meningitis and death. The incubation period of inhalation anthrax may be as long as six 
weeks. The fatality rate is high in settings of known exposure and may be higher when the 
diagnosis may not be initially suspected. Abdominal pain, vomiting and bloody diarrhea are 
exceptional clinical signs. 
 
Diagnostic Laboratory Tests 
Specimens to be examined are fluid or pus from a local lesion, blood and sputum. Stained 
smears from the local lesion or of blood from dead animals often show chains of large gram 
positive rods. Anthrax can be identified in dried smears by immunofluorescence staining 
techniques. When grown on blood agar plates, the organisms produce non hemolytic gray to 
white colonies with a rough texture and a ground glass appearance. Virulent anthrax cultures 
kill mice or guinea pigs upon intraperitoneal infection. 
 
Resistance / Immunity 
Active immunity to anthrax can be induced in susceptible animals by vaccination with 
live attenuated bacilli, with spore suspensions or with protective antigens from culture 
filtrates. It is advisable that animals that graze in suspected areas should be immunized for 
anthrax annually. 
In United States, the anthrax vaccine available is an aluminium hydroxide –precipitated 
preparation of protective antigen from sterile filtrate of cultures of a virulent non-
encapsulated strain. Two inoculations of this vaccine yield significant protection from 
inhalation anthrax in rhesus monkeys. In Russia, a live attenuated spore based vaccine has 
been widely used in large field trials. 
 
Treatment 
Many antibiotics are effective against anthrax in humans, but treatment must be started 
early. Ciprofloxacin is recommended for treatment of anthrax. Many antibiotics are active 
against B. anthracis, penicillin G, along with gentamycin or streptomycin has been used 
previously to treat anthrax. In cases of potential exposure to B. anthracis as an agent of 
biological warfare, prophylaxis with ciprofloxacin or doxcycline should be continued for 
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4weeks while three doses of the vaccine are given; or for 8weeks if no vaccine is 
administered.  
 
Prevention and Control 
Soil contaminated with an anthrax spores from the carcasses of dead animals may remain 
viable for decades. Spores can germinate in soil at pH of 6.5 at proper temperature. Grazing 
animals infected through injured mucous membranes serve to perpetuate the chain of 
infection. Contact with infected animals or with their hides, hair and bristles is the source of 
infection in humans. 
Control measures include: 
 
 Disposal of animal carcasses by burning or deep burial in lime pits. 
 Decontamination (usually by autoclaving) of animals’ products. 
 Protective clothing and gloves for handling potentially infected materials. 
 Active immunization of domestic animals with live attenuated vaccines. 
 
 
Bacillus Cereus 
 
Bacillus cereus is a large gram positive bacillus resembling B. anthracis, except that it is 
motile and lacks the glutamic capsule. Food poisoning caused Bacillus cereus has two distinct 
forms  
 
 The emetic type associated with fried rice.  
 Diarrheal type associated with meat dishes and sauces. 
 
B. cereus is a soil organism that commonly contaminates rice. When large amounts of 
rice are cooked and allowed to cool slowly, the B. cereus spores germinate and the vegetative 
cells produce the toxin during log phase growth or during sporulation. The diarrheal form has 
an incubation period of 1-24hrs and is manifested by profuse diarrhea with abdominal pain 
and cramps; fever and vomiting are uncommon. The enterotoxin may be preformed in the 
food or produced in the intestine. The presence of B. cereus in a patients stool is not sufficient 
to make a diagnosis of B. cereus disease since the bacteria may be present in normal stool 
specimens at concentration of 10
5 
bacteria or more per gram of food. B cereus causes eye 
infections when the organisms are introduced into the eye by foreign bodies associated with 
trauma. B. cereus has also been associated with localized infections and with systemic 
infections, including endocarditis, meningitis, pneumonia and osteomyletis. 
Other Bacillus species rarely associated with human disease include:  
 
 B. thuringiensis 
 B. popillae 
 B. sphaericus 
 B. larvae 
 B. lentimorbus 
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These are mainly pathogens for insects and some have been used as commercial 
insecticides. Genes for B. thuringiensis coding for insecticidal compounds have been inserted 
into the genetic material of some commercial plants.  
 
 
Clostridium Species 
 
The Clostridia are large anaerobic, gram positive motile rods. Pleomorphism is common 
and various forms may be seen in stained smears from cultures or wounds. Many decompose 
proteins or form toxins and some, do both. Their natural habitat is the soil or the intestinal 
tract of animals and humans; where they live as saprophytes. Among the pathogens are the 
organisms causing botulism, tetanus, gas gangrene and pseudo membranous colitis. 
 
Morphology and Identification 
Spores of Clostridia occur wider in diameter than most rods shaped bacteria.The spores 
occur centrally, subterminally or terminally with most motile species possessing peritrichous 
flagella. 
Clostridia grow well on the blood enriched media used to grow anaerobes and on other 
media used to culture anaerobes as well. Many Clostridia produce zone of hemolysis on 
blood agar. Their colonies could be raised or small. The Clostridia can ferment a variety of 
sugars, and many can digest proteins. They cause stormy fermentation (clot torn by gas). 
 
 
Clostridium Botulinum 
 
Clostridium botulinum causes botulism and it’s widespread. It can be found in soil, 
vegetables, fruits, leaves, silage, manure, mud from lakes and sea and occasionally in animal 
feces. The widespread occurrence of C. botulinum in nature is as a result of its ability to 
produce a potent neurotoxin in food and resistance of the spores to inactivation agents.These 
attributes combine to make it a formidable pathogen of humans and a host of animals and 
birds. Types of C. botulinum are distinguished by the antigenic type of toxin they produce. 
Spores of the organism are highly resistant to heat, withstanding 100ºC for several hours. 
Heat resistance is diminished at acidic (low) pH or high salt concentration. C. botulinum is 
motile with peritrichous flagellation and spores are oval or subterminal. As Clostridium 
botulinum grows, autolysis of the bacteria can occur, causing toxin to be liberated into the 
environment. Seven antigenic varieties of toxin A – G are known. Types A, B, and E (and 
occasionally F) are the principal causes of human illness. Type A and B have been associated 
with a variety of foods and type E predominantly with fish products. Type C produces a 
disease in birds called limberneck, while types D cause botulism in mammals. The molecular 
weight of this toxin is about 150000MW. Botulinum toxin is absorbed from the gut and binds 
to receptors of presynaptic membrane of motor neurons of the peripheral nervous system and 
cranial nerves. The toxins inhibit release of acetylcholine at the synapse, resulting in lack of 
muscle contraction and paralysis. The lethal doses for a human is probably about 1- 2 µg. The 
toxins are destroyed by heating for 20 minutes at 100ºC. 
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Pathogenesis 
Pathogenesis occurs as a result of intoxication from ingestion of food in which C. 
botulinum has grown and produced toxin. The most susceptible are people that feed on 
spiced, smoked, vacuum-packed or canned alkaline foods (preserved hams, large sausages, 
home preserved meats and vegetables) that are eaten without cooking. In such foods, it may 
not exhibit signs of spoilage. Spores of C. botulinum germinate; under anaerobic conditions, 
forming vegetative forms that grow and produce toxin. Symptoms begin 18-24hrs after 
ingestion of the toxic food with visual disturbances (in coordination of eye muscles, double 
vision) inability to swallow and speech difficulty. Death occurs from respiratory paralysis or 
cardiac arrest. Gastrointestinal symptoms are not regularly prominent. There is no fever and 
patients remain fully conscious until shortly before death. The mortality rate is high. Patients 
who recover do not develop antitoxin in the blood. 
In United States, infant botulism is more common than the classic form of paralytic 
botulism associated with the ingestion of toxin – contaminated food. The infants in the first 
months of life develop poor feeding, weakness and sighs of paralysis (“floppy baby”). Infant, 
botulism may be one of the causes of sudden infant death syndrome. C. botulinum and 
botulinum toxin can occur in the feces. It is assumed that C. botulinum spores could be in the 
babies’ food producing toxin in the babies’ gut. 
Honey has been implicated as a possible vehicle for the spores. Most of these infants 
recover with supportive therapy alone. 
 
Diagnostic Laboratory Tests 
Toxin can often be demonstrated in serum from the patient and may be found in leftover 
foods. Mice injected intraperitoneal die rapidly. Toxin may be demonstrated by passive 
hemogglutination or radioimmunoassay. 
 
Treatment 
Potent antitoxins to three types of botulinum toxins have been prepared in horses. Since 
the type responsible for an individual case is usually not known, trivalent (A, B, E) antitoxin 
must be promptly administered intravenously with customary precaution. Adequate 
ventilation must be maintained by mechanical aspirator; if necessary. The priorities involved 
in treatment are to remove unabsorbed toxin from the stomach and intestinal tract, to 
neutralize unfixed toxin by giving polyvalent antitoxin and to give relevant intensive care and 
support.  
 
Epidemiology, Prevention and Control 
Spores of C. botulinum are widely distributed in soil; they often contaminate vegetables, 
fruits and other materials. Canned foods or otherwise preserved, must be boiled for 20minutes 
before consumption. Strict regulation of commercial canning has largely overcome the danger 
of widespread outbreaks, but commercially prepared foods have caused deaths. A chief risk 
factor for botulism lies in home canned foods, particularly string beans, corn, peppers, olives, 
peas and smoked fish or vacuum packed fresh fish in plastic bags. Toxic food may be spoiled 
or rancid, and cans may swell or the appearance may be innocuous. The risk from home-
canned foods can be reduced if the food is boiled for more than 20 minutes before 
consumption. Toxoids are used for active immunization of cattle in South Africa. Botulism 
toxin is considered to be a major agent for bioterrorism and biological warfare. 
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Clostridium Tetani 
 
Clostridium tetani causes “tetanus” and is widely distributed in soil, in feces of horses 
and other animals. The organism under microscope appears as straight, slender rod with 
rounded ends. The fully developed terminal spore gives the organism the appearance of a 
drum stick with a large round ends. The tetanus bacillus is an obligate anaerobe, which is 
motile via numerous peritrichous flagella. It grows well in cooked meat broth and produces a 
thin spreading film when grown on enriched blood agar. Spores of some strains cannot be 
destroyed by boiling in water for up to 3hrs, or dry heat at 160
o
C for 1hr, or 5% phenol for 
2weeks. However, the spores could be destroyed using glutaraldehyde. Several types of C. 
tetani can be distinguished by specific flagellar antigens. All share a common O (somatic) 
antigen; which may be masked, and all produce the same antigenic type of neurotoxin, 
tetanospasmin. 
The vegetative cells of C. tetani produce the toxin tetanospasmin (MW 150000) that is 
cleared by a bacterial protease into two peptides (MW 50000 and 100000) linked by a 
disulfide bond. The toxin initially binds to receptors on the presynaptic membranes of motor 
neurons. It then migrates through a transport system to the cell bodies of these neurons to the 
spinal cord and brain stem. The toxin diffuses to terminals of inhibitory cells, (including both 
glycinergic inter neurons and aminobutyric- acid secreting neurons from the brain stem. The 
toxin degrades synaptobrevin; a protein required for docking of neurotransmitter that resides 
on the presynaptic membrane. Release of the inhibitory glycine and -aminobutyric acid is 
blocked, and the motor neurons are not inhibited. Hyperreflexia, muscles pain and spastic 
paralysis then results. Extremely small amounts of toxin can be lethal for humans. 
 
Pathogenesis 
C. tetani is not an invasive organism. The infection remains strictly localized in the area 
of devitalized tissue (wound, burn, injury, umbilical stump; surgical suture) from which the 
spores have been introduced. Germination of the spore and development of vegetative 
organism that produce toxin are aided by Necrotic tissue, presence of calcium salts and 
associated pyogenic infections, all of which aid establishment of low oxidation-reduction 
potential. The toxins released from vegetative cells reach the central nervous system and 
rapidly becomes fixed to receptors in the spinal cord and brain stem. The incubation period 
may range from 4-5 days to as many weeks. The disease is characterized by tonic contraction 
of voluntary muscles. Muscular spasms often involve first the area of injury and infection and 
then the muscles of the jaw (lockjaw) which contract so that the mouth cannot be opened. 
Gradually other voluntary muscles become involved, resulting in tonic spasms. Any external 
stimulus may precipitate a titanic generalized muscle spasm. The patient is fully conscious; 
and pain may be intense. Death usually results from interference with mechanics of 
respiration. 
 
Diagnosis 
The primary differential diagnosis of tetanus is strychnine poisoning. Anaerobic culture 
of tissues from contaminated wounds may yield C. tetani but neither preventive nor 
therapeutic use of antitoxin should ever be withheld pending such demonstration. Proof of 
isolation of C. tetani must rest on production of toxin and its neutralization by specific 
antitoxin. 
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Control 
Tetanus is a totally preventable disease. Tetanus toxoid immunization should be 
mandatory. Tetanus toxoid is produced by detoxifying the toxin with formalin and then 
concentrating it. Aluminum-salt-adsorbed toxoids are employed. Three injections of the 
immunization should be given. First is the initial course immunization then another dose 
about 1year later. This initial immunization should be carried out in all children during the 
early year of life. Thereafter, booster injections may be given to maintain serum level of more 
than 0.01 unit antitoxin per millimeter. Normally during vaccination, tetanus toxoid is 
combined with diphtheria toxoid and pertussis vaccine. 
 
Prevention and Treatment 
The results of treatment of tetanus are not satisfactory, thus prevention is all important. 
Prevention of tetanus depends upon: Active immunization with toxoids, Proper care of 
wounds contaminated with soil, Prophylactic use of antitoxin and administration of penicillin. 
Intramuscular administration of human antitoxin gives adequate systemic protection for 2-4 
weeks. It neutralizes the toxin that has not been fixed to nervous tissue. Patients who develop 
symptoms of tetanus should receive muscles relaxants, sedation and assisted ventilation. 
Sometimes they are given very large doses of antitoxin (3000 – 10000 units of tetanus 
immune globulin) intravenously in an effort to neutralize toxin that has not yet been bound to 
nervous tissue. Surgical debridement is vitally important because it removes the necrotic 
tissues that are essential for proliferation of the organisms. Penicillin strongly inhibits the 
growth of C. tetani and stops further toxin production. Antibiotics may also control associated 
pyogenic infection. 
When an individual previously immunized sustains a potentially dangerous wound, an 
additional dose of toxoid should be injected to restimulate antitoxin production. 
 
 
Other Groups of Medically Important Gram Positive Non Spore Formers 
Include: The Staphylococci 
 
The Staphylococci are Gram-positive spherical cells, usually arranged in grape-like 
irregular clusters. They grow readily on many types of media and are active metabolically, 
fermenting carbohydrates and producing pigments that vary from white to deep yellow. Some 
are members of the normal flora of the skin and mucous membranes of the humans; others 
cause suppuration, abscess formation; a variety of pyogenic infections and even fatal 
septicemia. The pathogenic Staphylococci often hemolyze blood, coagulate plasma, and 
produce a variety of extracellular enzymes and toxins. 
The most common type of food poisoning is caused by a heat-stable staphylococcal 
enterotoxin. The genus staphylococcus has at least 30 species. The three main species of 
medical importance are Staphylococcus aureus, Staphylococcus epidermidis, and 
Staphylococcus saprophyticus.  
Staphylococcus aureus is coagulase – positive, which differentiates it from other species. 
S. aureus is a major pathogen for humans. Almost every person will have some type of S. 
aureus infection during his/her lifetime, ranging in severity from food poisoning or minor 
skin infections to severe life- threatening infections. The coagulase negative staphylococci are 
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normal human flora and sometimes cause infection, often associated with implanted 
appliances and devices, especially in very young, old and immunocompromised patients. S. 
saprophyticus is a relatively common cause of urinary tract infections in young women. 
 
Morphology and identification 
 
Typical Organisms 
Staphylococci are spherical cells about 1µm in diameter arranged in irregular clusters. 
Young cocci strains strongly stain gram- positive, on aging, many cells become gram –
negative. Staphylococci are non- motile and do not form spores. They are found in cocci 
pairs, clusters, tetrads and chains. 
 
Culture and Growth Characteristics 
Staphylococci grow on most bacteriological media under aerobic or microaerophilic 
conditions. They grow rapidly at 37°C, but form pigments best at room temperature 20-25°C. 
Colonies on solid media are round, smooth, raised and glistening. Staphylococci produce 
catalase, which differentiates them from Streptococci. Staphylococci slowly ferment many 
carbohydrates, producing lactic acid but not gas. Staphylococci are relatively resistant to 
drying, heat 50°C for 30 minutes. They are resistant to many antimicrobial drugs e.g. 
Penicillin G, Ampicillin, Ticarcillin, Piperacillin, and Naficillin (Methicillin and Oxacillin). 
Several properties resident on the cell wall of Staphylococcus causes it to be antigenic; this 
ranges from the presence of peptidoglycan, teichoic acid to protein A. 
 
Enzymes and Toxins 
Staphylococci can cause diseases by their ability to multiply and spread widely in tissues 
and through their production of many extracellular substances. Some of these substances are 
enzymes, others are considered to be toxins though they may function as enzymes. Some of 
these include: 
 
Catalase 
Staphylococci produce catalase, which converts hydrogen peroxide (H2O2) into water and 
oxygen. The catalase test differentiates the Staphylococci which are positive, from the 
Streptococci, which are negative. 
 
Coagulase and Clumping Factor 
S. aureus produces coagulase, an enzyme – like protein that clots oxalated or citrated 
plasma. Coagulase binds to prothrombin; together they become enzymatically active and 
initiate fibrin polymerization. Coagulase may deposit fibrin on the surface of Staphylococci, 
perhaps altering their ingestion by phagocytic cells or their destruction within such cells. 
Clumping factor is a surface adhering compound that is responsible for adherence of the 
organisms to fibrinogen and fibrin. When mixed with plasma, S. aureus forms clumps. 
Clumping factor is distinct from coagulase. Other enzymes produced by S. aureus include 
hyaluronidase or spreading factor, a staphylokinase used for (fibrinolysis); proteinases, 
lipases, and β – lactamases, 
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Exotoxins 
 
Leukocidin 
The toxin of S. aureus has two components. It can destroy white blood cells of humans 
and rabbits. The two components act synergistically on the white blood cell membrane to 
form pores and increase cation permeability. Other toxins include the exfoliate toxins which 
yield the generalized desquamination of the staphylococcal scalded skin syndrome.  
Toxic shock syndrome toxin: Toxic shock syndrome is manifested by an abrupt onset of 
high fever, vomiting, diarrhea, rash, cardiac and renal failure in the most severe cases. Toxic 
shock syndrome associated S. aureus can be found in the vagina, in wounds or other localized 
infections, or in the throat but virtually never in the bloodstream. 
Enterotoxins: These are multiple (A-E, G-I, K-M) enterotoxins. They are heat stable and 
resistant to action of gut enzymes. As an important cause of food poisoning, enterotoxins are 
produced when S. aureus grows in carbohydrate and protein foods. Ingestion of 25µg of 
enterotoxin B results in vomiting and diarrhea. The emetic effect is probably the result of 
central nervous system stimulation (vomiting center) after the toxin acts on neural receptors 
in the gut.  
 
Pathogenesis 
Staphylococci, particularly S. epidermidis are members of the normal flora of the human 
skin, respiratory and intestinal tracts. Nasal carriage of S. aureus occur in 20- 25% of humans. 
Staphylococci are also found regularly on clothing, bed linen and other fomites in human 
environment. The pathogenic capacity of a given strain of S. aureus is the combined effect of 
extracellular factors and toxins together with the invasive properties of the strain. Pathogenic, 
invasive S. aureus produces coagulase, tend to produce yellow pigment and to be hemolytic. 
Non-pathogenic and non-invasive such as S. epidermidis are coagulase-negative and tend to 
be non-hemolytic. Such organisms rarely produce suppuration but may cause diseases in 
immunosuppressed persons. S. saprophyticus causes urinary tract infections in young women. 
A staphylococcal infection appears as a “pimple” hair follicle infection or abscess. There is 
usually an intense, localized, painful inflammatory infection that undergoes central 
suppuration and heals when the pus is drained. The wall of fibrin and the cells around the core 
of the abscess tends to prevent the spread of the organisms. S. aureus infections can also 
result from direct contamination of a wound. When S. aureus disseminates and bacteremia 
ensues, endocarditis, meningitis or pulmonary infection can result. Secondary localization 
within an organ or system is accompanied by the symptoms and signs of organ dysfunction 
and intense focal suppuration.  
 
Diagnostic Laboratory Test 
Specimens used for the diagnosis include: Surface swab, pus, blood, tracheal aspirate, or 
spinal fluid for culture, depending upon the localization of the process. 
Smears: Typical staphylococci are seen in stained smears of pus or sputum. 
Culture: Specimens inoculated on blood agar plates give rise to typical colonies in 
18hours at 37°C but hemolysis and pigment production may occur not until several days later. 
S. aureus ferment mannitol. Specimens contaminated with mixed flora can be cultured on 
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media containing 7.5% NaCl; the salt inhibits other flora but not S. aureus. Other tests 
include biochemical tests coagulase, susceptibility, serologic and typing tests. 
 
Epidemiology and Control 
Staphylococci are ubiquitous human parasites. The chief sources of infection are from 
shredded human lesions, fomites contaminated from such lesions, and the human respiratory 
tract and skin. Contact spread of infection has assumed added importance in hospitals, where 
large proportion of the staff and patient carry antibiotic–resistant staphylococci in the nose or 
on the skin. Cleanliness, hygiene and aseptic management of lesions can control the spread of 
staphylococci from lesions. Aerosols (glycols) and ultraviolet irradiation of air have little 
effect. In hospitals, the areas at highest risk of severe staphylococcal infections are the 
newborn nursery, intensive care units, operating rooms, and cancer chemotherapy wards. 
 
Treatments 
Most persons harbor Staphylococci on the skin and in the nose or throat. Even if the skin 
can be cleared of Staphylococci, re-infection by droplets will occur almost immediately. 
Because pathogenic microbes are commonly spread from one lesion to other areas of the body 
by fingers, clothing, antisepsis is important to control recurrence. 
Serious multiple skin infections (acne, furunculosis) occur most often in adolescents. 
Similar skin infections occur in patients receiving prolonged courses of corticosteroids.  
In acne, lipases of Staphylococci and Corynebacteria liberate fatty acids from lipids and 
thus cause tissue irritation. Tetracyclines are used for long term treatments. It is difficult to 
eradicate pathogenic Staphylococci from infected persons, because the organisms rapidly 
develop resistance to many antimicrobial drugs and the drugs cannot act in suppurative 
lesions. 
Bacteremia, endocarditis, pneumonia and other severe infections due to S. aureus require 
prolonged therapy with β-lactamase resistant penicillin. Vancomycin is often reserved for use 
with nafcillin –resistant Staphylococci if the infection is found to be due to non-β-lactamase 
producing S. aureus. Penicillin G is the drug of choice, but only a small percentage of S. 
aureus strains are susceptible to it.  
S. epidermidis infections are difficult to cure because they occur in prosthetic devices 
where the bacteria can sequester themselves in a biofilm. S. epidermidis is more often 
resistant to antimicrobial drugs than S. aureus; approximately 75% of S. epidermidis strains 
are nafcillin –resistant. 
Penicillin G –resistant S. aureus strains from clinical infections often produce 
penicillinase. 
 
 
The Streptococci 
 
The Streptococci are Gram – positive spherical bacteria that characteristically form pairs 
or chains during growth. They are widely distributed in nature. Some are members of the 
normal human flora; Streptococci elaborate a variety of extracellular substances and enzymes. 
Streptococci are a heterogeneous group of bacteria and no one system suffices to classify 
them. Twenty species including Streptococcus pyogenes (group A), Streptococcus agalactiae 
(group B) and the Enterococci (group D) are characterized by combinations of features; 
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colony growth characteristics; hemolysis patterns on blood agar (α-hemolysis, β-hemolysis or 
non-hemolysis). 
Classification of Streptococci: 
The classification of Streptococci into major categories has been based on a series of 
observations: 
Colony morphology and hemolytic reactions on blood agar, Serologic specificity of the 
cell wall group- specific substance (Lancefield classification), Biochemical reactions and 
resistance to chemical and physical factors. Ecologic features: Streptococci of particular 
medical interest include: Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus 
faecalis and Streptococcus bovis. S. pyogenes is the main human pathogen associated with 
local and systemic invasion and post streptococcal immunologic disorders. They belong to the 
group A antigen containing Streptococci. 
Streptococcus agalactiae: These are the group B Streptococci. They are members of the 
normal flora of the female genital tract and an important cause of neonatal sepsis and 
meningitis. They are β- hemolytic and produce zones of hemolysis that are only slightly 
larger than the colonies. 
Streptococcus pneumoniae: They are pneumococci and are α-hemolytic. Their growth is 
inhibited by optochin and colonies are bile soluble. Other species include: Viridians 
Streptococci, which are the most prevalent members of the normal flora of the upper 
respiratory tract and are important for the healthy state of the mucous membranes there.  
 
Morphology and Identification 
Individual cocci are spherical or ovoid and are arranged in chains. Streptococci are Gram 
positive. However, as culture ages and the bacteria die, they loose their Gram-positivity and 
appear to be Gram- negative, and this can occur after overnight incubation. 
Most group A, B and C strains produce capsules composed of hyaluronic acid. Most 
streptococci grow in solid media as discoid colonies, usually 1-2mm in diameter. Growths of 
streptococci tend to be poor on solid media or in broth unless enriched with blood or tissue 
fluids. 
 
Toxins and Enzymes 
More than 20 extracellular products that are antigenic are elaborated by group A 
streptococci, including streptokinase. (fibrinolysin). Streptokinase is produced by many 
strains of group A β-hemolytic Streptococci. It transforms the plasminogen of human plasma 
into plasmin, an active proteolytic enzyme that digests fibrin and other proteins. 
Hyaluronidase splits hyaluronic acid, an important component of the ground substance of 
connective tissue. This hyaluronidase aids in spreading infecting microorganisms (spreading 
factor). 
Hemolysins: Many streptococci are able to hemolyse red blood cells into varying degrees. 
Complete disruption of erythrocytes with release of hemoglobin is called β-hemolysis. 
Incomplete lysis of erythrocytes with the formation of green pigment is called α-hemolysis. β-
hemolytic group A,  
S. pyogenes when cultured in Blood agar elaborates to be β- hemolysis (streptolysins- 
with complete disruption of erythrocytes and release of hemoglobin).  
Streptolysin Q and S: Streptolysin Q is responsible for some of the hemolysis seen when 
growth cuts deep into the medium in blood agar plates. Streptolysin S is the agent responsible 
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for hemolytic zones around streptococcal colonies growing on the surface of the blood agar 
plates. It is elaborated in the presence of serum.  
 
Pathogenesis 
Infections can be divided into several categories: Diseases attributable to invasion by β-
hemolytic group A streptococcus, Diseases attributable to local infection with β- hemolytic 
group A S. pyogenes and their by products, Infective endocarditis, Invasive group A 
streptococcal infections, streptococcal toxic shock syndrome and scarlet fever and diseases 
attributable to invasion by β- hemolytic group A Streptococci (S. pyogenes). Here, the portal 
of entry determines the principal clinical picture. In each case, there is a diffuse and rapidly 
spreading infection that involves the tissues and extends along the lymphatic pathways only 
with minimal local suppuration.  
Erysipelas: if the portal of entry is the skin, erysipelas results with massive brawny 
edema and a rapidly advancing margin of infection. 
Cellulitis: Streptococcal cellulitis is an acute, rapidly spreading infection of the skin and 
subcutaneous tissues. It follows infection associated with mild trauma, burns, wounds, or 
surgical incisions, pain, tenderness, swelling and erythema occur. Cellulitis is differentiated 
from erysipelas by two clinical findings; in cellulitis, the lesion is not raised and the line 
between the involved and uninvolved tissue is indistinct. 
Sepsis: Infection of traumatic or surgical wounds with Streptococci results in sepsis or 
surgical scarlet fever. The most common infection due to β-hemolytic Streptococci is 
streptococcal sore throat. Virulent group A Streptococci adhere to the pharyngeal epithelium 
by means of lipoteichoic acid-covered surface pili. In neonates and small children, the sore 
throat occurs as sub acute nasopharyngitis with a thin serious discharge, and little fever but 
with a tendency of the infection to extend to the middle ear, the mastoid, and the meninges. 
The cervical lymph nodes are usually enlarged. The illness may persist for weeks. In older 
children and adults, the disease is more acute and is characterized by intense nasopharyngitis, 
tonsillitis, and intense redness, and edema of the mucous membranes with purulent exudates, 
enlarged tender, cervical lymph nodes; and usually a high fever.  
 
Infective Endocarditis 
Acute endocarditis occurs when in the course of bacteremia; hemolytic streptococci, 
pneumococci, and other bacteria may settle on normal or previously deformed heart values, 
producing acute endocarditis. Rapid destruction of the valves frequently leads to fatal cardiac 
failure in days or weeks, unless a prosthetic device can be inserted during antimicrobial 
therapy. 
Various Streptococci, particularly enterococci, cause urinary tract infections. Anaerobic 
Streptococci occur in the normal female genital tract, the mouth, and the intestine. They may 
give rise to suppurative lesions, sometimes alone, but most often in association with other 
anaerobes, particularly bacteroides. The pus usually has a foul odor. 
 
Diagnostic Laboratory Tests 
Specimens to be obtained depend on the nature of the streptococcal infection. A throat 
swab, pus or blood is obtained for culture. Serum is obtained for antibody determinations. 
Smears from pus often show single cocci or in pairs, rather than definite chains. Cocci are 
sometimes gram-negative because the organisms are no longer viable and have lost their 
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ability to retain blue dye (crystal violet) and be gram-positive. When specimens suspected of 
containing streptococci are cultured on blood agar plates, cultures will grow hemolytic group 
A streptococci (e.g. in sepsis), within hours or a few days. Certain α-hemolytic streptococci 
and enterococci may grow slowly on blood cultures. However, in cases of suspected 
endocarditis cultures occasionally do not turn positive within few days. 
 
Epidemiology, Preventions and Control 
Many Streptococci are members of the normal flora of the human body. They cause 
disease only when established in parts of the body where they do not normally occur. To 
prevent such accidents, particularly in the course of surgical procedures on the respiratory, 
gastrointestinal and urinary tracts that results in temporary bacteremia, antimicrobial agents 
are often administered prophylactically to persons with known heart valve deformity. The 
ultimate source of group A Streptococci is a person harboring the organisms. The individual 
may have a clinical or sub clinical infection or may be a carrier, distributing Streptococci 
directly to other persons via droplets from the respiratory tract or skin. The nasal discharges 
of a person harboring β- hemolytic Streptococci are the most dangerous sources for spread of 
these microbes. The infected udder of a cow yields milk that may cause epidemic spread of β-
hemolytic Streptococci. Immunologic grouping and typing of Streptococci are valuable tools 
for epidemiologic tracing of the transmission chain.  
Control procedures are directed mainly at the human source: 
 
 Detection and early antimicrobial therapy administration is crucial. Prompt 
eradication of Streptococci from early infections can effectively prevent the 
development of post streptococcal disease. This requires maintenance of adequate 
penicillin levels in tissues for 10days; Erythromycin is an alternative drug of choice.  
 Eradication of group A Streptococci from carriers. This is especially important when 
carriers are in areas such as obstetric delivery rooms, operating rooms, classrooms or 
nurseries. Unfortunately, it is often difficult to eradicate β-hemolytic Streptococci 
from permanent carriers and individuals may occasionally have to be shifted away 
from sensitive areas for some time. 
 Dust control, ventilation, air filtration, ultraviolet light and aerosol mists are all of 
doubtful efficacy in the control of streptococcal transmission. Milk should always be 
pasteurized. 
 Group B Streptococci account for most cases of neonatal sepsis at present. They are 
derived from the mother’s genital tract where carriage is asymptomatic. Neonatal 
illness maybe favored by deficiency of maternal antibody. Group B streptococcal 
disease in the newborn can be prevented by drug prophylaxis in a mother with 
positive cultures and in the setting of premature labor or prolonged rupture of the 
membranes. 
 
Treatments 
All β-hemolytic group Streptococci are sensitive to penicillin G and most are sensitive to 
erythromycin. Some are resistant to tetracycline. Α-hemolytic Streptococci and Enterococci 
vary in their susceptibility to antimicrobial agents. Aminoglycosides often enhance the rate of 
bactericidal action of penicillin on Streptococci, particularly Enterococci. In acute 
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streptococcal infections, every effort must be made to rapidly eradicate Streptococci from the 
patients, eliminate the antigenic stimulus (before day 8), and thus prevent post streptococcal 
disease. 
Antimicrobial drugs are also very useful in preventing reinfection with β-hemolytic group 
A Streptococci in rheumatic fever patients. 
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